company background image
POLX logo

Polarean Imaging AIM:POLX Stock Report

Last Price

UK£0.015

Market Cap

UK£18.7m

7D

0%

1Y

-74.6%

Updated

24 Nov, 2024

Data

Company Financials +

POLX Stock Overview

Operates as a drug-device manufacturer and service provider for noble gas polariser devices in Canada, the United Kingdom, and the United States. More details

POLX fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Polarean Imaging plc Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Polarean Imaging
Historical stock prices
Current Share PriceUK£0.015
52 Week HighUK£0.085
52 Week LowUK£0.01
Beta0.29
11 Month Change14.81%
3 Month Change-13.89%
1 Year Change-74.59%
33 Year Change-97.18%
5 Year Change-92.25%
Change since IPO-90.31%

Recent News & Updates

Polarean Imaging (LON:POLX) Is In A Good Position To Deliver On Growth Plans

Oct 16
Polarean Imaging (LON:POLX) Is In A Good Position To Deliver On Growth Plans

Recent updates

Polarean Imaging (LON:POLX) Is In A Good Position To Deliver On Growth Plans

Oct 16
Polarean Imaging (LON:POLX) Is In A Good Position To Deliver On Growth Plans

Here's Why Polarean Imaging (LON:POLX) Must Use Its Cash Wisely

Jan 09
Here's Why Polarean Imaging (LON:POLX) Must Use Its Cash Wisely

Is Polarean Imaging (LON:POLX) In A Good Position To Invest In Growth?

Sep 11
Is Polarean Imaging (LON:POLX) In A Good Position To Invest In Growth?

Is Polarean Imaging (LON:POLX) In A Good Position To Invest In Growth?

Feb 09
Is Polarean Imaging (LON:POLX) In A Good Position To Invest In Growth?

We're Keeping An Eye On Polarean Imaging's (LON:POLX) Cash Burn Rate

Oct 09
We're Keeping An Eye On Polarean Imaging's (LON:POLX) Cash Burn Rate

Polarean Imaging (LON:POLX) Is In A Good Position To Deliver On Growth Plans

Dec 15
Polarean Imaging (LON:POLX) Is In A Good Position To Deliver On Growth Plans

We Think Shareholders Will Probably Be Generous With Polarean Imaging plc's (LON:POLX) CEO Compensation

Jul 07
We Think Shareholders Will Probably Be Generous With Polarean Imaging plc's (LON:POLX) CEO Compensation

Here's Why We're Watching Polarean Imaging's (LON:POLX) Cash Burn Situation

Jun 07
Here's Why We're Watching Polarean Imaging's (LON:POLX) Cash Burn Situation

Insider Buying: The Polarean Imaging plc (LON:POLX) Independent Chairman Just Bought 6.6% More Shares

Mar 18
Insider Buying: The Polarean Imaging plc (LON:POLX) Independent Chairman Just Bought 6.6% More Shares

Polarean Imaging (LON:POLX) Is In A Good Position To Deliver On Growth Plans

Mar 09
Polarean Imaging (LON:POLX) Is In A Good Position To Deliver On Growth Plans

Polarean Imaging (LON:POLX) Shareholders Have Enjoyed An Impressive 135% Share Price Gain

Feb 01
Polarean Imaging (LON:POLX) Shareholders Have Enjoyed An Impressive 135% Share Price Gain

Should You Take Comfort From Insider Transactions At Polarean Imaging plc (LON:POLX)?

Dec 28
Should You Take Comfort From Insider Transactions At Polarean Imaging plc (LON:POLX)?

What Type Of Shareholders Own The Most Number of Polarean Imaging plc (LON:POLX) Shares?

Nov 30
What Type Of Shareholders Own The Most Number of Polarean Imaging plc (LON:POLX) Shares?

Shareholder Returns

POLXGB Medical EquipmentGB Market
7D0%-0.4%2.2%
1Y-74.6%-2.7%8.0%

Return vs Industry: POLX underperformed the UK Medical Equipment industry which returned -2.7% over the past year.

Return vs Market: POLX underperformed the UK Market which returned 8% over the past year.

Price Volatility

Is POLX's price volatile compared to industry and market?
POLX volatility
POLX Average Weekly Movement6.9%
Medical Equipment Industry Average Movement6.3%
Market Average Movement4.8%
10% most volatile stocks in GB Market10.3%
10% least volatile stocks in GB Market2.6%

Stable Share Price: POLX has not had significant price volatility in the past 3 months compared to the UK market.

Volatility Over Time: POLX's weekly volatility has decreased from 16% to 7% over the past year.

About the Company

FoundedEmployeesCEOWebsite
201629Chris Von Jakopolarean.com

Polarean Imaging plc operates as a drug-device manufacturer and service provider for noble gas polariser devices in Canada, the United Kingdom, and the United States. It engages in the research, development, and commercialization of novel imaging solutions with a non-invasive and radiation-free functional imaging platform. The company also offers XENOVIEW, a hyperpolarized contrast agent indicated for use with magnetic resonance imaging (MRI) for evaluation of lung ventilation in adults and pediatric patients aged 12 years and older; and measurement station, chest coil, and dose delivery inhalation bags.

Polarean Imaging plc Fundamentals Summary

How do Polarean Imaging's earnings and revenue compare to its market cap?
POLX fundamental statistics
Market capUK£18.71m
Earnings (TTM)-UK£6.82m
Revenue (TTM)UK£1.49m

12.5x

P/S Ratio

-2.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
POLX income statement (TTM)
RevenueUS$1.87m
Cost of RevenueUS$1.03m
Gross ProfitUS$836.63k
Other ExpensesUS$9.38m
Earnings-US$8.55m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.0071
Gross Margin44.78%
Net Profit Margin-457.39%
Debt/Equity Ratio0%

How did POLX perform over the long term?

See historical performance and comparison